<p><strong>Gapping down<br /></strong><u>In reaction to disappointing earnings/guidance:</u> SWI -14.3%, UIS -12.5%, NTY -12.2%, ZRAN -11.0%, IPCM -9.0% (light volume), FBP -8.6%, CBAK -7.8%, ELX -7.3%, WMS -4.2%, PCL -4.2% (downgraded to Sell from Neutral at UBS), , ALV -4.1%, CX -3.7%, DAI -2.7%, BSX -2.0%, CNI -1.9% (also downgraded to Neutral from Buy at UBS), SANM -1.7%, BP -1.5%.</p><p><u>Select financial related names showing weakness</u>: FTBK -14.6% (pulling back from yesterday's 100% jump), NBG -7.8%, BBVA -4.1%, SNV -4.1% (filed for a mixed shelf offering for an indeterminate amount; announces $600 mln aggregate offering of common stock; announces ongoing elements of capital plan and announces rights plan), AIG -4.1% (downgraded to Underperform from Market Perform at Keefe, Bruyette), HBAN -2.5% (downgraded to Hold from Buy at Deutsche Bank), IRE -3.3%, STD -3.0%, ING -2.9%, RBS -2.4%, HBC -2.2%, DB -1.9%, GS -1.2%, CS -0.6%, .</p><p><u>Select metals/mining stocks trading lower:</u> RTP -1.9%, BBL -1.9%, BHP -1.7%, MT -1.3%, GG -1.0%.</p><p><u>Select drug related names showing weakness:</u> AZN -2.3%, GSK -2.2%, SNY -1.9%.</p><p><u>Other news:</u> OTE -7.3% (still checking), YMI -7.2% (announces controlled equity offering of up to 7.75 mln shares), AKS -1.5% (filed for a debt securities shelf offering for an indeterminate amount), MTL -1.2% (announces offering of preferred shares and preferred ADS by certain selling shareholders), OTEX -1.1% (Open Text announces acquisition of Shares of Burntsand Inc).</p><p><u>Analyst comments</u>: MSO -1.8% (downgraded to Hold from Buy at Morgan Joseph), GOOG -0.8% (removed from Conviciton Buy List at Goldman).</p><p><strong>Gapping up</strong><br /><u>In reaction to strong earnings/guidance</u>: EL +11.8%, LXK +9.5%, TLAB +8.3%, PPDI +7.6% (also confirms Takeda receives NDA approval of NESINA from Japanese Ministry of Health, Labour and Welfare; upgraded to Neutral from Sell at Goldman ), CAVM +7.6%, DSW +6.4%, CMI +5.2%, HMA +5.2%, MMM +4.4%, CIT +4.4%, MSPD +4.3%, VECO +3.8%, ENTG +3.6%, WU +3.6%, SUPG +3.6% (light volume), VECO +3.0%, DD +2.6%, CRUS +2.5%, RCII +2.3%, AAN +2.3%, RSH +2.3%, X +1.8%.</p><p><u>Other news</u>: NEXM +80.0% (receives FDA clearance for PrevOnco phase 2 study as first-line therapy for HCC), BSPM +13.4% (received new advertising approval from Shaanxi State Food and Drug Administration for marketing Xin Aoxing Oleanolic Acid Capsules), DVAX +9.7% (reports positive data on universal flu vaccine candidate), WWIN +8.9% (prices 1.38 mln common shares at $6.10/share ), APPY +8.0% (still checking), ANX +2.2% (ADVENTRX Pharma to resubmit ANX-530 NDA in 4Q10 ), PRGN +1.4% (entered into shipbuilding contracts with a Chinese shipyard), WFT +1.1% (Cramer makes positive comments on MadMoney).</p><p><u>Analyst comments</u>: PLCE +1.7% (upgraded to Overweight from Neutral at JP Morgan), MRVL +1.6% (upgraded to Buy from Hold at Deutsche Bank), IGT +1.5% (initiated with a Buy at KeyBanc Capital Mkts), TASR +1.3% (upgraded to Neutral from Underweight at JP Morgan), RDS.A +0.5% (upgraded to Neutral from Underweight at JP Morgan),</p>